Literature DB >> 16673309

Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.

G Feldmann1, J Nattermann, H D Nischalke, M Gorschlüter, T Kuntzen, G Ahlenstiel, T Gerhardt, M Wolff, T Sauerbruch, U Spengler, F L Dumoulin.   

Abstract

BACKGROUND AND STUDY AIMS: The diagnosis of bile duct cancer is hampered by the low sensitivity of intraductal brush cytology and forceps biopsy. In the present study real-time reverse transcription polymerase chain reaction (RT-PCR) assays for the detection of human aspartyl (asparaginyl) beta-hydroxylase (HAAH) and homeobox B7 (HoxB7) mRNA from intraductal brush cytology specimens were established. Both markers are overexpressed in biliary cancer cell lines and possibly involved in the pathogenesis of bile duct cancer. PATIENTS AND METHODS: RT-PCR assays were validated for detection limit, in-assay variability, and inter-assay variability. Target gene expression was determined in brush cytology specimens from 16 patients with biliary strictures (11 with histologically proven cholangiocarcinomas and five with benign biliary strictures).
RESULTS: The assay was quick (about 3 h), highly sensitive (with detection limits between 3 and 106 molecules), and reproducible (maximum in-assay variability 10.3 %, maximum inter-assay variability 11.8 %). The sensitivity of routine brush cytology alone was 36 % (four of 11 cases), with 100 % specificity. A combination with detection of HoxB7 and HAAH mRNA increased the overall diagnostic sensitivity to 82 %.
CONCLUSIONS: Detection of these markers using the RT-PCR assays from brush cytology specimens described here may prove to be a useful additional tool for the diagnosis of bile duct carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673309     DOI: 10.1055/s-2006-925065

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

1.  Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma.

Authors:  Michael H Chapman; Robert Tidswell; James S Dooley; Neomal S Sandanayake; Virginie Cerec; Maesha Deheragoda; Alvin J X Lee; Charles Swanton; Fausto Andreola; Stephen P Pereira
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

2.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.

Authors:  G Feldmann; N Habbe; S Dhara; S Bisht; H Alvarez; V Fendrich; R Beaty; M Mullendore; C Karikari; N Bardeesy; M M Ouellette; W Yu; A Maitra
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

3.  Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.

Authors:  Gyem Tshering; Palden Wangyel Dorji; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

4.  Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.

Authors:  Hans Dieter Nischalke; Volker Schmitz; Carolin Luda; Katharina Aldenhoff; Cordula Berger; Georg Feldmann; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

5.  mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.

Authors:  Tae Ho Kim; Jae Hyuck Chang; Hee Jin Lee; Jean A Kim; Yeon Soo Lim; Chang Whan Kim; Sok Won Han
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

6.  A novel predictive equation for potential diagnosis of cholangiocarcinoma.

Authors:  Ratthaphol Kraiklang; Chawalit Pairojkul; Narong Khuntikeo; Kanokwan Imtawil; Sopit Wongkham; Chaisiri Wongkham
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.